Covidien is making an $860 million bet that people would much rather swallow a pill-sized camera than undergo a traditional colonoscopy. Dublin, Ireland–based Covidien, announced over the weekend that it will pay $30 per share for ...
AMAG Pharmaceuticals has received a notice of three-month extension from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) for Feraheme (ferumoxytol) injection to be used for intravenous (IV) therapy. ...
Tags: AMAG Pharma, Intravenous Use
The US Food and Drug Administration (FDA) has cleared Given Imaging’s next-generation video capsule, called PillCam SB 3. The 11 mm x 26 mm video capsule is helpful in detecting small bowel abnormalities related to Crohn's disease, ...
Tags: PillCam SB 3, Drug
American Regent, a subsidiary of a Daiichi Sankyo Group Company named Luitpold Pharmaceuticals, has won USFDA approval for Injectafer (ferric carboxymaltose injection) for the treatment of iron deficiency anemia (IDA). A parenteral iron ...
Tags: Iron Deficiency Anemia, Medicine
Takeda Pharmaceutical Company, AMAG Pharmaceuticals' European commercial partner, has submitted a type-II variation to the European Medicines Agency (EMA) for label expansion of Rienso (ferumoxytol). The approval will allow the use of ...
Tags: Takeda, EMA Approval
The US Food and Drug Administration (FDA) has accepted for review AMAG Pharmaceuticals' supplemental new drug application (sNDA) for Feraheme (ferumoxytol) injection for Intravenous (IV) use. The sNDA filed is to expand the indication for ...
Tags: FDA, Pharmaceuticals, oral iron treatment
Researchers at Nottingham Trent University, UK, have identified a novel and natural method which uses 'nano-rust' particles to fortify potatoes with iron, a move which could help prevent iron deficiency anemia. Anemia affects nearly a ...
Tags: UK, potatoes, nano-rust particles
AMAG Pharmaceuticals has submitted a supplemental new drug application (sNDA) for intravenous (IV) use of Feraheme injection, to FDA. The company is seeking approval for the label expansion of Feraheme to include all iron deficiency ...
Tags: Feraheme Injection, AMAG, SNDA
The EMA Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AMAG Pharmaceuticals' ferumoxytol, an iron deficiency anemia (IDA) therapy. The intravenous (IV) iron therapy, indicated for the treatment of ...
Tags: AMAG Pharmaceuticals, iron deficiency anemia(IDA)therapy
The European Commission has granted marketing authorization for AMAG Pharmaceuticals' intravenous iron therapy, ferumoxytol, to treat iron deficiency anemia (IDA) in chronic kidney disease (CKD) patients. The marketing authorization is ...
Tags: AMAG Pharmaceuticals, Intravenous Iron Therapy, chronic kidney disease
Takeda Pharmaceutical Company has introduced AMAG's iron deficiency anaemia drug, ferumoxytol, in the Europe. Ferumoxytol is launched as Rienso in Europe and is called as Feraheme in the US. Both the US and European regulatory bodies ...
Tags: Anaemia Drug, adult chronic kidney disease, treatment with Rienso